| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |